2.1. Cell Lines, Constructs and Primers

QZ Qifei Zou
YH Ying Hou
HW Haibo Wang
KW Kui Wang
XX Xianglei Xing
YX Yong Xia
XW Xuying Wan
JL Jun Li
BJ Binghua Jiao
JL Jingfeng Liu
AH Aimin Huang
DW Dong Wu
HX Hongjun Xiang
TP Timothy M. Pawlik
HW Hongyang Wang
WL Wan Yee Lau
YW Yizheng Wang
FS Feng Shen
request Request a Protocol
ask Ask a question
Favorite

Human embryonic kidney 293 cells, and human HCC cell lines that included Huh-7, SMMC-7721, MHCC-97L and EHBC-512, were maintained as previously described [24]. The ASPH coding sequence was amplified from a cDNA library of EHBC-512. The enzymatic loss ASPH mutant was prepared through site mutagenesis of histidine-679, a reported essential residue for ASPH catalytic activities [19,25], to alanine using an in vitro mutagenesis system (Promega, Madison, WI). The coding sequence of vimentin was synthesized by Shanghai Genepharma (Shanghai, China). The shRNA sequences for silencing ASPH and vimentin were 5′-GCGCAGTGTGAGGATGAT-3′ and 5′-GCTAACTACCAAGACACTATT-3′, respectively. The lentivirus of vimentin, wild-type (WT) or mutant ASPH and the shRNA against human ASPH or vimentin were constructed, packaged and harvested by Shanghai Genepharma. The FLAG-ASPH and HA-vimentin plasmids were constructed through the introduction of ASPH and vimentin coding sequence into pFLAG-CMV (Sigma, St. Louis, MO) and pCMV-HA vectors (Clontech, Kusatsu, Shiga Japan). The primers are listed in Table S1.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A